AestheticSource launches Revision Skincare in the UK and Ireland
Clinical skincare brand distributor AestheticSource has launched a new skincare brand onto the UK and Irish markets.
AestheticSource is the official distributor for Revision Skincare in the UK and Ireland. Described as a “results-driven, medical grade cosmeceutical range”, the US brand is now available for practitioners in the UK.
The brand’s driver is to change the way professional skincare results are achieved, without compromising the skin’s long-term health. Products use bioavailable peptides to help combat visible signs of ageing and are formulated with prebiotic technology to harness skin’s natural microbiome. The majority of the retail products contain a skin neutral pH to support long-term skin health.
According to Aesthetic Source, Revision Skincare was the first brand in the US to utilise vitamin C ester THD ascorbate as a superior alternative to L-ascorbic acid and the only skincare company to use this ingredient at a 30% concentration (as of 2019).
The brand is launching initially with 12 products, including hero products C+ Correcting Complex 30%, NectifirmADVANCED, Revox 7, D·E·J Face Cream and D·E·J Night Face Cream. Additional products will be introduced later in the year.
“The addition of Revision Skincareto our portfolio represents a very exciting development for new clinic partners looking for a brand that resonates with current consumer demand for innovative technology and multi-tasking products presented in an easy to communicate and stunning package,” said Lorna McDonnell Bowes, chief executive of AestheticSource.
“With an exceptional success story in the US, we are ready to share the science, marketing, PR, training and commercial opportunities with clinics who relish the idea of carrying a top US brand during the launch phase ‘over here’”.
